Bayer targets COPD in a new discovery alliance with Haplogen, Evotec

Bayer is adding COPD to its list of discovery targets. 

The German pharma company has tied the knot with a collaborative effort that’s been underway between Vienna-based Haplogen and Evotec — a high profile discovery shop in Europe.